Exciting updates from our content and strategy team
April 23, 2025 |
Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.
As we usher in the new financial year, we are pleased to welcome a new Strategy Director to Cuttsy+Cuttsy and celebrate the accomplishments of our talented team members through some well-deserved promotions.
At the beginning of the month, we welcomed Oli Bailey as our new Strategy Director. As Strategy Director, Oli brings a critical perspective to Cuttsy+Cuttsy, guiding our approach to develop impactful solutions that resonate with our clients and the patients and communities we support. Oli carries a wealth of experience in healthcare communications, that will be invaluable to our team as we continue to grow and evolve.
Speaking about joining the team, Oli shared, “I’m incredibly excited to join such a talented and passionate group of individuals. It’s clear that this agency is driven by a commitment to creating work that truly matters, and I can’t wait to get started on helping to shape the strategy that will keep us at the forefront of healthcare communications.”
But that’s not all! We also had some amazing growth within our Content and Strategy team this month. We’re proud to announce several well-deserved promotions that highlight the hard work, passion, and dedication of our talented colleagues:
Scott Palmer: promoted to Principal Patient Writer
Beth Bhuva: promoted to Principal Medical Writer
Katie Breen: promoted to Senior Patient Writer
These promotions are a testament to their commitment to creating content that truly makes a difference in people’s lives. Their efforts have consistently raised the bar, and we couldn’t be prouder of their achievements. Congratulations to all three of them on these exciting milestones!
Here’s to a month of growth, new beginnings, and well-earned recognition. We’re excited for what the future holds for the team and look forward to seeing their continued impact.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Long-term clinical trial engagement is a behavioural challenge – not just an informational one
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are telling the truth — just not to you
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
When what matters to patients is hard to measure
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Permission to pause: making treatment breaks part of the cancer care conversation
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
Why faster trials make participant understanding more important than ever
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants reject bad design, not technology
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
It’s time to stop calling adverse events ‘manageable’
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
The value: why localisation pays off across global trials
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.